UBC Therapeutics Initiative (TI) in partnership with Cochrane Hypertension invite you to our Christmas Special "Best Evidence on Tap" event on Monday, December 7, 2015 at 6:30 pm at Steamworks Brew Pub in downtown Vancouver (near Waterfront Skytrain Station). Guest speaker: Dr....
This HealthNewsReview podcast features an important topic: Is there overdiagnosis of diabetes? Is the creation of the term and the diagnosis of “pre-diabetes” another form of over diagnosis? The topic was addressed 4 years ago in...
This Letter reviews clinical evidence for use of antipsychotics for depression. In Canada, two antipsychotic drugs are approved to treat major depressive disorder (MDD) that is not responsive to other treatment. Quetiapine (Seroquel XR) is approved...
UBC Therapeutics Initiative (TI) in partnership with UBC Continuing Professional Development (CPD) are proud to deliver a 2-day course on combining evidence & clinical pharmacology to improve drug therapy on 23-24 October 2015 at Surrey Memorial Hospital. The course will provide up-to-date, evidence-based...